Athersys, Inc. (ATHXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 7, 2026, 9:30 AM EST
Athersys Market Cap
Athersys has a market cap or net worth of $6.18 thousand as of April 8, 2026. Its market cap has decreased by -97.67% in one year.
Market Cap
6.18K
Enterprise Value
n/a
Revenue
80.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 12, 2007, Athersys's market cap has decreased from 34.78M to 6.18K, a decrease of -99.98%. That is a compound annual growth rate of -36.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 6.18K | 9,859.68% |
| Dec 31, 2025 | 62.00 | - |
| Dec 31, 2024 | 62.00 | -99.99% |
| Dec 29, 2023 | 1.23M | -91.28% |
| Dec 30, 2022 | 14.16M | -93.33% |
| Dec 31, 2021 | 212.32M | -38.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Statera Biopharma | 7.26K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| Syros Pharmaceuticals | 5.37K |